bf/NASDAQ:REGN_icon.jpeg

COM:REGENERON

Regeneron Pharmaceuticals, Inc.

  • Stock

USD

Last Close

744.50

22/11 21:00

Market Cap

116.07B

Beta: -

Volume Today

1.03M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
49.50M
-
99.61M
101.24%
183.72M
84.44%
318.97M
73.62%
562.75M
76.43%
938.67M
66.80%
1.28B
36.72%
1.67B
29.82%
1.93B
16.08%
2.18B
12.55%
average payables
50.44M
-
80.72M
60.05%
120.23M
48.95%
137.97M
14.75%
156.58M
13.49%
198.19M
26.57%
318.15M
60.53%
446.80M
40.44%
519.75M
16.33%
576.60M
10.94%
average receivables
792.45M
-
954.59M
20.46%
1.24B
30.17%
1.54B
23.91%
1.79B
16.45%
2.11B
17.61%
2.46B
16.55%
3.39B
38.07%
5.08B
49.57%
5.68B
11.96%
book value per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
211.62
19.18%
capex per share
-1.60
-
-3.31
107.32%
-6.58
98.74%
-4.89
25.68%
-2.56
47.56%
-3.55
38.49%
-3.93
10.80%
-5.71
45.19%
-5.22
8.59%
-15.10
189.14%
-5.53
63.37%
capex to depreciation
-3.79
-
-6.32
66.60%
-9.05
43.18%
-4.89
46.00%
-1.87
61.65%
-2.59
37.93%
-2.04
20.98%
-2.61
27.54%
-1.93
25.98%
-4.74
145.60%
capex to operating cash flow
-0.27
-
-0.45
67.30%
-0.51
13.69%
-0.35
31.79%
-0.21
39.97%
-0.17
16.32%
-0.18
1.30%
-0.23
32.78%
-0.08
66.80%
-0.32
313.69%
-0.12
63.50%
capex to revenue
-0.07
-
-0.12
59.02%
-0.17
39.87%
-0.11
36.24%
-0.05
55.92%
-0.06
22.96%
-0.05
4.30%
-0.07
32.39%
-0.03
52.52%
-0.13
286.80%
-0.04
66.13%
cash per share
7.09
-
8.95
26.28%
10.14
13.32%
9.92
2.20%
13.26
33.64%
26.04
96.46%
29.43
13.03%
33.34
13.25%
53.88
61.61%
72.29
34.18%
days of inventory on hand
165.29
-
229.42
38.79%
221.74
3.34%
486.38
119.34%
667.51
37.24%
967.95
45.01%
660.52
31.76%
624.66
5.43%
292.19
53.22%
561.84
92.28%
days payables outstanding
145.52
-
177.16
21.74%
131.02
26.05%
164.40
25.48%
163.80
0.37%
183.47
12.01%
195.10
6.34%
154.98
20.57%
84.46
45.50%
137.82
63.19%
days sales outstanding
154.65
-
131.71
14.84%
130.55
0.88%
121.03
7.30%
122.72
1.40%
122.01
0.58%
124.04
1.66%
176.75
42.50%
137.09
22.44%
159.78
16.55%
debt to assets
0.17
-
0.21
21.79%
0.15
29.36%
0.09
40.91%
0.13
53.31%
0.05
60.65%
0.05
8.40%
0.25
422.82%
0.13
46.67%
0.12
12.89%
debt to equity
0.26
-
0.32
22.69%
0.23
28.82%
0.14
39.65%
0.19
39.53%
0.07
63.03%
0.06
8.73%
0.39
509.63%
0.18
53.58%
0.15
17.14%
dividend yield
0.01
-
0.01
37.12%
0.01
32.97%
0.01
31.05%
earnings yield
0.02
-
0.01
46.44%
0.01
34.81%
0.02
104.91%
0.03
28.69%
0.06
102.32%
0.05
14.92%
0.07
30.97%
0.12
79.00%
0.06
53.59%
0.04
24.86%
enterprise value
26.92B
-
41.09B
52.62%
55.52B
35.12%
38.39B
30.85%
39.87B
3.86%
39.54B
0.82%
40.10B
1.41%
52.48B
30.89%
66.57B
26.83%
77.59B
16.56%
enterprise value over ebitda
35.42
-
49.00
38.35%
44.34
9.51%
28.85
34.95%
19.17
33.54%
15.60
18.62%
18.15
16.30%
13.57
25.21%
7.09
47.73%
15.00
111.41%
ev to operating cash flow
46.12
-
55.29
19.86%
41.72
24.55%
26.05
37.55%
30.50
17.07%
18.01
40.94%
16.50
8.39%
20.05
21.49%
9.40
53.11%
15.47
64.58%
ev to sales
12.79
-
14.57
13.93%
13.53
7.16%
7.90
41.62%
6.79
14.03%
5.89
13.22%
5.10
13.46%
6.18
21.13%
4.14
32.95%
6.37
53.89%
free cash flow per share
4.36
-
4.08
6.59%
6.33
55.39%
9.18
44.94%
9.73
5.96%
16.79
72.62%
18.32
9.08%
18.62
1.64%
61.77
231.76%
31.73
48.64%
41.47
30.71%
free cash flow yield
0.02
-
0.01
37.33%
0.01
17.43%
0.03
114.34%
0.03
3.46%
0.04
73.76%
0.05
8.51%
0.04
21.00%
0.10
153.79%
0.04
55.04%
0.05
7.37%
graham net net
4.08
-
3.96
2.82%
3.02
23.79%
-0.74
124.41%
5.95
908.30%
19.38
225.40%
20.24
4.48%
13.88
31.45%
42.87
208.92%
59.66
39.15%
graham number
44.09
-
44.35
0.59%
70.17
58.23%
90.42
28.85%
121.05
33.88%
203.40
68.03%
210.41
3.45%
274.36
30.39%
552.48
101.37%
439.17
20.51%
income quality
1.38
-
2.14
55.24%
2.09
2.01%
1.65
21.36%
1.09
33.71%
0.90
17.66%
1.15
27.89%
0.75
35.11%
0.88
17.67%
1.16
31.82%
intangibles to total assets
-0.21
-
-0.12
43.59%
-0.11
5.17%
-0.12
9.97%
-0.17
36.85%
-0.15
11.82%
-0.22
47.08%
-0.18
16.95%
-0.27
47.16%
0.03
111.66%
0
100%
interest coverage
16.37
-
22.43
37.07%
87.91
291.84%
184.95
110.39%
82.79
55.24%
89.87
8.56%
73.17
18.58%
62.86
14.10%
156.14
148.40%
79.78
48.91%
-55.44
169.49%
interest debt per share
5.65
-
8.41
49.03%
8.17
2.87%
5.88
28.08%
11.26
91.55%
5.99
46.84%
6.81
13.83%
40.74
497.90%
32.89
19.27%
32.50
1.19%
inventory turnover
2.21
-
1.59
27.95%
1.65
3.46%
0.75
54.41%
0.55
27.13%
0.38
31.04%
0.55
46.54%
0.58
5.74%
1.25
113.78%
0.65
47.99%
invested capital
0.26
-
0.32
22.69%
0.23
28.82%
0.14
39.65%
0.19
39.53%
0.07
63.03%
0.06
8.73%
0.39
509.63%
0.18
53.58%
0.15
17.14%
market cap
26.95B
-
41.28B
53.15%
55.95B
35.55%
38.44B
31.29%
39.98B
4.00%
40.30B
0.80%
41.00B
1.74%
51.98B
26.78%
66.75B
28.41%
77.27B
15.76%
93.71B
21.28%
net current asset value
1.25B
-
1.18B
6.05%
1.43B
21.41%
1.39B
2.78%
2.98B
114.17%
4.98B
67.39%
6.84B
37.36%
6.62B
3.32%
13.85B
109.41%
15.51B
11.98%
net debt to ebitda
-0.04
-
-0.23
471.24%
-0.35
53.11%
-0.04
88.27%
-0.05
29.31%
-0.30
470.06%
-0.41
36.55%
0.13
131.73%
-0.02
115.26%
0.06
407.82%
net income per share
4.33
-
3.46
20.17%
6.17
78.39%
8.55
38.56%
11.27
31.80%
22.65
101.00%
19.38
14.47%
32.65
68.52%
76.40
133.99%
40.51
46.98%
37.05
8.53%
operating cash flow per share
5.96
-
7.39
23.92%
12.91
74.82%
14.07
8.96%
12.29
12.64%
20.34
65.50%
22.25
9.38%
24.33
9.34%
66.99
175.34%
46.82
30.11%
47
0.37%
payables turnover
2.51
-
2.06
17.86%
2.79
35.22%
2.22
20.31%
2.23
0.37%
1.99
10.72%
1.87
5.96%
2.36
25.89%
4.32
83.50%
2.65
38.72%
receivables turnover
2.36
-
2.77
17.42%
2.80
0.88%
3.02
7.87%
2.97
1.38%
2.99
0.58%
2.94
1.64%
2.07
29.82%
2.66
28.93%
2.28
14.20%
research and ddevelopement to revenue
0.41
-
0.45
10.36%
0.39
12.42%
0.42
6.92%
0.35
16.31%
0.33
7.82%
0.39
18.54%
0.32
16.65%
0.18
43.78%
0.30
63.10%
0.34
14.67%
return on tangible assets
0.12
-
0.08
32.35%
0.10
26.83%
0.11
12.12%
0.12
2.33%
0.18
54.99%
0.12
35.36%
0.17
47.75%
0.25
44.57%
0.15
38.73%
revenue per share
21.50
-
28.02
30.37%
39.82
42.09%
46.41
16.56%
55.22
18.98%
62.19
12.63%
72.01
15.78%
78.97
9.67%
152.05
92.54%
113.66
25.25%
122.94
8.16%
roe
0.22
-
0.14
37.02%
0.17
27.11%
0.20
15.65%
0.20
3.08%
0.28
43.09%
0.19
31.65%
0.32
67.02%
0.43
35.02%
0.19
55.51%
roic
0.17
-
0.10
39.96%
0.13
30.58%
0.16
20.67%
0.15
7.59%
0.24
60.92%
0.15
36.09%
0.21
33.46%
0.34
64.80%
0.16
53.32%
sales general and administrative to revenue
0.16
-
0.18
14.38%
0.20
14.14%
0.24
18.58%
0.22
7.20%
0.23
3.13%
shareholders equity per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
211.62
19.18%
stock based compensation to revenue
0.09
-
0.11
15.60%
0.11
2.66%
0.12
2.98%
0.09
25.01%
0.06
26.27%
0.06
7.29%
0.05
13.90%
0.04
26.36%
0.06
59.08%
tangible asset value
2.57B
-
3.00B
16.65%
4.29B
42.78%
5.31B
23.94%
7.63B
43.61%
10.51B
37.77%
14.35B
36.47%
14.16B
1.29%
25.61B
80.83%
21.75B
15.07%
tangible book value per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
203.07
14.36%
working capital
1.99B
-
1.89B
5.19%
2.62B
39.03%
2.93B
11.82%
4.63B
57.82%
6.61B
42.73%
8.77B
32.70%
9.95B
13.45%
17.07B
71.60%
18.22B
6.71%

All numbers in USD (except ratios and percentages)